1-(1,1,1,2,3,3,3-heptadeuteriopropan-2-ylamino)-3-(1H-indol-4-yloxy)propan-2-ol

This compound is a deuterated pharmaceutical intermediate, specifically a heptadeuterated analog of a propan-2-ylamino derivative. Its significance lies in its use as a building block in the synthesis of deuterated drugs, where the incorporation of deuterium atoms can influence metabolic stability.